Theratechnologies Files 6-K, Announces Press Release
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Theratechnologies dropped a 6-K with a press release on May 29th - check the release for deets.
AI Summary
Theratechnologies Inc. filed a Form 6-K on May 29, 2025, to report a press release dated May 29, 2025. The filing does not contain specific financial figures or operational updates beyond the announcement of the press release itself.
Why It Matters
This filing indicates Theratechnologies Inc. is making a public announcement, the details of which are contained in the attached press release, potentially impacting investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Filer of the 6-K report
- May 29, 2025 (date) — Date of the press release and filing
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary who signed the filing
FAQ
What is the subject of the press release filed as Exhibit 99.1?
The filing does not specify the subject of the press release; it is only referenced as Exhibit 99.1 dated May 29, 2025.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on May 29, 2025.
What is Theratechnologies Inc.'s principal executive office address?
The principal executive office is located at 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.
Does Theratechnologies Inc. file annual reports under Form 20-F or 40-F?
The company indicates it files annual reports under Form 20-F.
Who signed this Form 6-K on behalf of Theratechnologies Inc.?
The Form 6-K was signed by Jocelyn Lafond, General Counsel and Corporate Secretary.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 29, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..